Recombinant Anti-TIE2 Anticorps (A324259)

Anti-TIE2 Antibody [Research Grade Biosimilar] - Low endotoxin, Azide free

Recombinant human monoclonal antibody to TIE2.

ELISA, FACS, Functional Assay, In Vivo

Human, Mouse, Rat

Human

Monoclonal

IgG4SP - Human IgG4 with S228P mutation

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

> 90% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

Angiopoietin 1 receptor, Angiopoietin-1 receptor, CD202b, CD202b antigen, EC 2.7.10.1, Endothelial tyrosine kinase, Endothelium specific receptor tyrosine kinase 2, hTIE 2, hTIE2, Hyk, p140 TEK, soluble TIE2 variant 1, soluble TIE2 variant 2, Tek, tek tyrosine kinase, TEK tyrosine kinase endothelial, TEK tyrosine kinase, endothelial, TIE 2, TIE2_HUMAN, Tunica interna endothelial cell kinase, Tyrosine kinase with Ig and EGF homology domains 2, Tyrosine kinase with Ig and EGF homology domains-2, Tyrosine protein kinase receptor TEK, Tyrosine protein kinase receptor TIE 2, Tyrosine-protein kinase receptor TEK, Tyrosine-protein kinase receptor TIE 2, Tyrosine-protein kinase receptor TIE-2, Venous malformations multiple cutaneous and mucosal, venous malformations, multiple cutaneous and mucosal, VMCM, VMCM 1, VMCM1